| Vol. 14.37 – 26 September, 2023 |
| |
|
|
| By small molecule compound screening targeting 142 epigenetic enzymes, researchers identified that bromodomain-containing protein BRD9 was a key chromatin regulator to orchestrate the stemness of pancreatic cancer stem cells. [Gastroenterology] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
| |
|
|
| The device showed the potential to enable subcutaneous survival of encapsulated islet cells, in vivo in awake, freely moving, immune-competent animals. [Proceedings Of The National Academy Of Sciences Of The United States Of America] |
|
|
|
| Researchers demonstrated that incorporating human pancreatic decellularized extracellular matrix within alginate microcapsules resulted in a significant increase in Glucose Stimulation Index and total insulin secreted by encapsulated human islets, compared to free islets and islets encapsulated in only alginate. [Acta Biomaterialia] |
|
|
|
| In this randomized and placebo-controlled trial, a total of 73 patients were randomly assigned to receive intravenous infusion of umbilical cord-derived mesenchymal stem cells or placebo, three times at four-week intervals and followed up for 48 weeks. [Stem Cells Translational Medicine] |
|
|
|
| Scientists describe scalable techniques for generating 10,000–100,000 organoids that further mature in 4–5 weeks into α- and β-like cells with glucose-responsive insulin and glucagon release. [Star Protocols] |
| |
|
|
| Fructose could be taken up and metabolized by PDAC cells and provided an adaptive survival mechanism for PDAC cells under glucose deficient conditions. [Cancer Research] |
|
|
|
| In vivo and in vitro experiments revealed that fatty acid-binding protein 4 (FABP4) induced macrophage-related inflammation to promote pancreatic cancer cell migration, invasion, and metastasis under obese condition. [Cancer Letters] |
|
|
|
| Scientists demonstrated that CDK1 was correlated with prognosis and was highly expressed in pancreatic cancer tissue and gemcitabine-resistant cells [Cell & Bioscience] |
|
|
|
| Through multi-omics analyses, investigators discerned that solute carrier family 35 member F2 (SLC35F2) influenced the transcriptome and inhibited ferroptosis in pancreatic cancer cells. [Oncogene] |
|
|
|
|
| The authors discuss current state of the art and consider knowledge gaps concerning the interface of the islet beta cell with immune infiltrates, with a focus on T cells. [Molecular Metabolism] |
|
|
|
| Scientists describe how various nutrients are sensed, transported and metabolised in alpha cells, providing an integrative model for the metabolic regulation of glucagon secretion and action. [Journal Of Endocrinology] |
|
|
|
|
| The $5 million grant will enable Oncolytics to continue the next stage of its research focused on a clinical trial with Oncolytics’ proprietary reovirus pelareorep in combination with modified FOLFIRINOX chemotherapy, with or without an immune checkpoint inhibitor. [Oncolytics Biotech Inc.] |
|
|
|
|
| October 29 – November 1, 2023 New York, New York, United States |
|
|
|
|
|
| The University of Tennessee – Memphis, Tennessee, United States |
|
|
|
| Beth Israel Deaconess Medical Center & Harvard Medical School – Boston, Massachusetts, United States |
|
|
|
| Northwestern University – Chicago, Illinois, United States |
|
|
|
| The Sidney Kimmel Cancer Center – Philadelphia, Pennsylvania, United States |
|
|
|
| University of Missouri – Columbia, Missouri, United States |
|
|
|
|